[1] Singer M, Deutschman CS, Seymour CW, et al.The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. [2] Rudd KE, Johnson SC, Agesa KM, et al.Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219): 200-211. [3] Kim TS, Choi DH.Liver Dysfunction in Sepsis[J]. Korean J Gastroenterol, 2020, 75(4): 182-187. [4] Sarin SK, Choudhury A.Management of acute-on-chronic liver failure: an algorithmic approach[J]. Hepatol Int, 2018, 12(5): 402-416. [5] Sarin SK, Choudhury A.Acute-on-chronic liver failure: terminology, mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(3): 131-149. [6] 毕占虎, 王临旭, 连建奇. 慢加急性肝衰竭的定义、预后评估及诊治进展[J]. 临床肝胆病杂志, 2022, 38(7): 1671-1676. [7] Fernández J, Acevedo J, Wiest R, et al.Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis[J]. Gut, 2018, 67(10): 1870-1880. [8] Liu XQ, Zhang XY, Ying Y, et al.The role of prophylactic antibiotics in hepatitis B virus-related acute-on-chronic liver failure patients at risk of bacterial infection: a retrospective study[J]. Infect Dis Poverty, 2021, 10(1): 44. [9] 周盼, 张剑. 成人ICU脓毒症肝损伤的发病率研究及预后分析[J/OL]. 世界最新医学信息文摘, 2020, 20(94): 19-22. [10] Johnson AL, Ratnasekera IU, Irvine KM, et al.Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study[J]. BMJ Open Gastroenterol, 2021, 8(1): e000695. [11] 罗文才, 王秀杰, 高崇箫. 肝功能状况对脓毒症病情严重程度及预后的影响[J]. 胃肠病学和肝病学杂志, 2016, 25(8):933-936. [12] Igna R, Gîrleanu I, Cojocariu C, et al.The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure[J]. J Clin Med, 2022, 11(18): 5410. [13] Mannes M, Schmidt CQ, Nilsson B, et al.Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis[J]. Semin Immunopathol, 2021, 43(6): 773-788. [14] van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis[J]. Immunity, 2021, 54(11): 2450-2464. [15] Assinger A, Schrottmaier WC, Salzmann M, et al. Platelets in Sepsis: An Update on Experimental Models and Clinical Data[J]. Front Immunol, 2019 Jul 17;10: 1687. [16] Hu X, Chung AY, Wu I, et al.Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways[J]. Immunity, 2008, 29(5): 691-703. [17] Palaga T, Buranaruk C, Rengpipat S, et al.Notch signaling is activated by TLR stimulation and regulates macrophage functions[J].Eur J Immunol, 2008, 38(1): 174-83. [18] Chen W, Liu J, Ge F, et al.Long Noncoding RNA HOTAIRM1 Promotes Immunosuppression in Sepsis by Inducing T Cell Exhaustion[J]. J Immunol, 2022, 208(3): 618-632. |